The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00596401 |
Recruitment Status
:
Active, not recruiting
First Posted
: January 17, 2008
Last Update Posted
: October 5, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Helicobacter Pylori Eradication Gastric Cancer Medical Care Cost |
Study Type : | Observational |
Actual Enrollment : | 3000 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | The Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer and the Medical Care Cost in Iijima Town |
Study Start Date : | September 2007 |
Estimated Primary Completion Date : | August 2019 |
Estimated Study Completion Date : | August 2019 |

Group/Cohort |
---|
1
HP eradication group
|
2
No eradication group
|
3
No Hp group
|
- the annual incidence of gastric cancer in Iijima town [ Time Frame: 10 years ]
- The annual medical care cost in Iijima town [ Time Frame: 10 years ]
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years to 69 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- People who live in Iijima town at their age of 19 to 69 years

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00596401
Japan | |
Showa Inan General hospital | |
Komagane, Nagano, Japan, 399-4191 |
Study Director: | Akira Horiuchi, M.D. | Showa Inan General Hospital |
Responsible Party: | Akira Horiuchi, Digestive Disease Center, Showa Inan General Hospital |
ClinicalTrials.gov Identifier: | NCT00596401 History of Changes |
Other Study ID Numbers: |
sihp20076 |
First Posted: | January 17, 2008 Key Record Dates |
Last Update Posted: | October 5, 2017 |
Last Verified: | October 2017 |
Additional relevant MeSH terms:
Stomach Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Neoplasms Digestive System Diseases Gastrointestinal Diseases Stomach Diseases |